Vol. 12 No. 2 (2026) | Research Results in Pharmacology

Experimental Pharmacology

Neuroprotective effects of tryptanthrin in the rat model of transient focal cerebral ischemia

Mark B. Plotnikov, Galina A. Chernysheva, Vera I. Smolyakova, Oleg I. Aliev, Anton N. Osipenko, Nina D. Anfinogenova, Andrei I. Khlebnikov

75-85
https://doi.org/10.18413/rrpharmacology.12.1067
11-06-2026 Abstract: 24 | PDF: 10 | HTML: 12 |
- PDF
- HTML
Experimental Pharmacology

Effect of a new acetylaminohexanic acid derivative on wound healing and wound blood supply in mice with a mutation in the Agouti gene with inhibition of NOS isoform expression

Alexey A. Khentov, Albina V. Miller, Leonid V. Pazhinsky, Anton A. Bolgov, Irina A. Tatarenkova, Polina K. Sunyaykina, Lyudmila M. Danilenko

11-19
https://doi.org/10.18413/rrpharmacology.12.1048
29-05-2026 Abstract: 94 | PDF: 77 | HTML: 26 |
- PDF
- HTML
Experimental Pharmacology

Modeling of cisplatin-induced acute kidney injury and its correction using polydatin

Aleksandr S. Netrebenko , Tatiana G. Pokrovskaya, Elena G. Netrebenko; Margarita V. Edamenko; Dmitriy B. Kuzmin, Aleksandr V. Paulauskas, Dmitry S. Skuryatin, Ekaterina I. Skuryatina, Igor A. Efremenko, Tatyana V. Avtina

35-45
https://doi.org/10.18413/rrpharmacology.12.1072
31-05-2026 Abstract: 62 | PDF: 30 | HTML: 17 |
- PDF
- HTML
Experimental Pharmacology

Ghrelin and orexin 1 type receptors effects on impulsive component of decision making in the Iowa Gambling Task Animal Model under stress conditions Действие Ghsr1a и Ox1r в модели IGTпри воздействии стресса

Maria A. Netesa, Andrei A. Lebedev, Edgar A. Sekste, Galina P. Kosyakova, Victor A. Lebedev, Eugenii R. Bychkov, Petr D. Shabanov

46-59
https://doi.org/10.18413/rrpharmacology.12.1036
11-06-2026 Abstract: 20 | PDF: 8 | HTML: 7 |
- PDF
- HTML
Experimental Pharmacology

In silico exploring the mechanisms of action of diterpenoids from Rabdosia serra against lung cancer through inhibition of the anti-apoptotic pathway

Hung Duc Nguyen

60-74
https://doi.org/10.18413/rrpharmacology.12.1084
11-06-2026 Abstract: 27 | PDF: 16 | HTML: 11 |
- PDF
- HTML
Clinical Pharmacology

From PDC to integral quantitative metrics: an innovative approach to assessing adherence to combination pharmacotherapy in outpatient practice

Sergey B. Fitilev, Irina I. Shkrebniova, Dmitry A. Klyuev

1-10
https://doi.org/10.18413/rrpharmacology.12.1102
29-05-2026 Abstract: 81 | PDF: 42 | HTML: 28 |
- PDF
- HTML
Clinical Pharmacology

The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities

Sergey A. Pribylov, Kristina O. Leonidova, Vladislav S. Pribylov, Evgeniya V. Gavrilyuk, Nadezhda N. Pribylova, Lvovskaya A. Mikhailovna

86-94
https://doi.org/10.18413/rrpharmacology.12.1055
11-06-2026 Abstract: 32 | PDF: 12 | HTML: 6 |
- PDF
- HTML
Pharmacological reviews

Reasons for using carnitine in managing dioxins-induced metabolic dysfunction-associated steatotic liver disease: A scoping review

Marwan Al-Nimer, Vian Wasta Esmail, Tavga Aziz

20-34
https://doi.org/10.18413/rrpharmacology.12.729
31-05-2026 Abstract: 48 | PDF: 25 | HTML: 15 |
- PDF
- HTML